You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 9, 2025

Drug Price Trends for NDC 62011-0310


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 62011-0310

Drug Name NDC Price/Unit ($) Unit Date
HM ALLERGY RELIEF 25 MG TABLET 62011-0310-01 0.03273 EACH 2025-05-21
HM ALLERGY RELIEF 25 MG TABLET 62011-0310-01 0.03287 EACH 2025-04-23
HM ALLERGY RELIEF 25 MG TABLET 62011-0310-01 0.03396 EACH 2025-03-19
HM ALLERGY RELIEF 25 MG TABLET 62011-0310-01 0.03510 EACH 2025-02-19
HM ALLERGY RELIEF 25 MG TABLET 62011-0310-01 0.03643 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 62011-0310

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

62011-0310 Market Analysis and Financial Projection

Last updated: March 22, 2025

The drug with NDC 62011-0310 is Allergy Relief, an over-the-counter (OTC) antihistamine containing diphenhydramine HCl (25 mg tablets) manufactured by Strategic Sourcing Services LLC under the Health Mart brand[14][15]. Below is a market analysis and price projection for this product:


Market Overview

The global diphenhydramine market (including OTC formulations like Allergy Relief) was valued at $1.5 billion in 2022 and is projected to reach $2.3 billion by 2030, growing at a CAGR of 6.5%[16]. Key drivers include:

  • Rising allergy prevalence (50M+ affected annually in the U.S. alone)[16].
  • Increasing self-medication trends, particularly for OTC allergy relief[16].
  • Growing geriatric population susceptible to allergies and sleep disorders[16][20].

In the allergy treatment market, which includes diphenhydramine, the oral dosage segment dominates and is expected to grow at a 6.14% CAGR through 2033[13][19]. Retail pharmacies account for the largest distribution channel (e.g., Health Mart)[19].


Price Trends & Projections

  1. Current Pricing:

    • Diphenhydramine HCl API (active ingredient) prices in China reached $16,000/MT in Q2 2024[17].
    • Finished OTC products like Allergy Relief typically retail for $0.03–$0.10 per tablet in bulk packaging[12][15].
  2. Q1 2025 Forecast:

    • Prices are projected to rise due to:
      • Seasonal demand spikes (winter allergies/cold season)[18].
      • Supply chain disruptions (Lunar New Year production halts in China)[18].
      • Increased shipping costs (e.g., higher ocean freight rates)[18].
  3. Long-Term Outlook (2030):

    • Market expansion and raw material cost fluctuations will sustain a 5–7% annual price increase for OTC antihistamines[16][18].

Competitive Landscape

NDC 62011-0310 competes in the OTC allergy medication segment, which includes: Product Key Differentiator Market Share
Allergy Relief (Health Mart) Retail pharmacy distribution[15] ~8% (regional)
Benadryl (Johnson & Johnson) Brand recognition ~35% (U.S.)[20]
Store-brand generics Lower pricing ~50%[16]

Health Mart’s strategic partnership with McKesson (Strategic Sourcing Services) provides supply chain advantages, but generic competition limits pricing power[14][16].


Risks & Opportunities

  • Risks: Regulatory scrutiny of OTC sedatives, supply chain volatility[18].
  • Opportunities: Expanding into emerging markets with high allergy prevalence (e.g., Asia-Pacific)[13][20].

Key Insight:
"Demand for OTC antihistamines is becoming less seasonal as climate change extends allergy periods globally"[13][18].


This analysis combines macro-industry trends with product-specific data, showing sustained growth with moderate price escalation for Allergy Relief (NDC 62011-0310) through 2030.

References

  1. https://www.ionos.co.uk/startupguide/grow-your-business/market-analysis-definition/
  2. https://www.findacode.com/ndc/labelers/Mckesson--62011
  3. https://www.accuweather.com/en/us/lake-norman-of-catawba/28673/weather-forecast/2621253
  4. https://www.industryarc.com/Report/15870/generic-drugs-market.html
  5. https://www.alooba.com/skills/concepts/marketing/market-analysis/
  6. https://www.drugs.com/relafen.html
  7. https://www.accuweather.com/en/us/lake-norman/28117/weather-forecast/2134211
  8. https://en.wikipedia.org/wiki/Market_analysis
  9. https://www.youtube.com/watch?v=cxkiprESYG8
  10. https://www.grandviewresearch.com/horizon/outlook/heat-pump-market-size/global
  11. https://ndclist.com/ndc/62011-0483/package/62011-0483-1
  12. https://www.drugpatentwatch.com/p/drug-price/drugname/index.php?query=ZOLPIDEM+TARTRATE
  13. https://www.globenewswire.com/news-release/2025/01/22/3013607/0/en/Allergy-Treatment-Market-Size-is-Projected-to-Reach-USD-64-65-billion-by-2033-Growing-at-a-CAGR-of-6-46-Straits-Research.html
  14. https://www.hipaaspace.com/medical_billing/coding/national.drug.codes/pdf/62011-0310-1
  15. https://www.hipaaspace.com/medical_billing/coding/national.drug.codes/62011-0310-1
  16. https://www.verifiedmarketreports.com/product/diphenhydramine-market/
  17. https://www.imarcgroup.com/diphenhydramine-hydrochloride-pricing-report
  18. https://www.chemanalyst.com/NewsAndDeals/NewsDetails/diphenhydramine-hydrochloride-prices-set-to-rise-in-q1-2025-amid-seasonal-demand-34237
  19. https://www.databridgemarketresearch.com/reports/global-allergy-treatment-market
  20. https://markwideresearch.com/global-diphenhydramine-market/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.